Open Clinical Trials for Head and Neck Cancer

Head and Neck Cancer Studies Currently Recruiting Participants at Simmons Cancer Research Center at Southern Illinois University

Protocol Title	Study #	Study Group
A Multicenter Trial of FDG-PET/CT Staging of Head & Neck Cancer & Its Impact on the NO Neck Surgical Treatmet in head & Neck Cancer Patients	11-062	SCI
Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer	RTOG 1016	RTOG
A T1 Translational Multicenter Randomized Phase II Study of Temsirolimus Versus Cetuximab Plus Temsirolimus in Patients with Recurrent/Metastatic Head and Neck Cancer, Who Failed Prior EGFR Based Therapy.	10-087	SCI
A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors	RTOG 1008	RTOG
RETAIN: Resistance Training and Physical Functuinuing in Patients with head and neck cancer	07-146	SIU IM
A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer	09-122	SCI
Phase II Trial of Dasatinib (BMS 354825) for Recurrent or Metastatic c-KIT Expressing Adenoid Cystic Carcinoma and for Non-Adenoid Cystic Malignant Salivary Tumors	09-029	SCI
Treatment of Childhood Nasopharyngeal Carcinoma With Neoadjuvant Chemotherapy and Concomitant Chemoradiotherapy	COG ARAR0331	SIU COG
A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab In Patients With Recurrent Or Metastatic Head and Neck Cancer	ECOG E1305	CICCOP
A Phase II Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally Advanced Resected Head and Neck Cance	RTOG 0920	RTOG
Cancer Care/Symptom Management
A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients With Bone Metastases Starting Zoledronic Acid Treatment	SWOG S0702	CICCOP

Although our objective is to provide an updated listing of available clinical trials please note that a listing here does not guarantee that a trial is open or available to any specific patient and that there may be additional trials available that are not listed. Complete information is only available from a treating physician.

Contact Information:

Simmons Cancer Institute Clinical Trials Office
Mail Code 9677 Fax (217) 545-6823

Kathy Robinson, PhD,
Director of Clinical Trials
(217) 545-1946
: Allicent Curry, RN,BSN, OCN
Research Nurse
(217) 545-7929

SIU COG

Carol Peterson, RN, CCRP (217) 545-7377

SIU IM

Amanda Fogleman, B.S. (217) 545-0592

Krista Whitlock (217) 545-7750

SIU Thoracic

Theresa Boley, RN, MSN, APN/FNP-BC, CCRP (217) 545-5000
: Cathy Leslie, RN, CCRP (217) 545-8184; Mary Ray, MS (217) 545-7420

RTOG: Radiation Therapy Oncology Group:

Diana Weyhenmeyer, RN, MA, OCN (217) 544-6464 ext. 45591

CICCOP: Central Illinois Community Clinical Oncology Program
Memorial Medical Center CICCOP Research Contacts:

Treatment/Cancer Control:

Holly Thomas (217) 788-4178

Stephanie Allbritton (217) 788-3544

Brooke Trickey (217) 217-788-3560

Karen Graber (217) 588-2961

Chrissy Tucker (217) 788-4444
Sunny Hampsey (217) 788-4233

Back to Open Clinical Trials